Concepedia

Author

Lillian Skidmore

Ambrx (United States)

Also Known As

L. Skidmore, Lillian K. Skidmore, Lillian Skidmore

47

Publications

402

Citations

5

H-Index

20

Concepts

All Affiliations

Ambrx (United States)
LS

About

Lillian Skidmore is an author at Ambrx (United States) specializing in protein engineering, natural sciences, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

191

2

Natural Sciences

2

2

191

3

Biochemistry

2

2

191

4

Biomolecular Engineering

2

2

191

5

Cell Biology

2

2

191

Lillian Skidmore

×

5

Publications

382

Citations

5

H-Index

YearCitations

FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents

James Mu, Jason Pinkstaff, Zhihua Li,

Diabetes

2011

158

ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers

Lillian Skidmore, Sukumar Sakamuri, Nick Knudsen,

Molecular Cancer Therapeutics

2020

151

Abstract 639: Site specific conjugation of ARX-788, an antibody drug conjugate (ADC) targeting HER2, generates a potent and stable targeted therapeutic for multiple cancers

Robin Humphreys, Jessica Kirtely, Amha Hewit,

Cancer Research

2015

33

Nonclinical Development of Next-generation Site-specific HER2-targeting Antibody–drug Conjugate (ARX788) for Breast Cancer Treatment

Prathap Nagaraja Shastri, Jingjing Zhu, Lillian Skidmore,

Molecular Cancer Therapeutics

2020

29

Preclinical Characterization of ARX517, a Site-Specific Stable PSMA-Targeted Antibody–Drug Conjugate for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Lillian Skidmore, David Mills, Ji Young Kim,

Molecular Cancer Therapeutics

2024

11

Page 1